AAOS 2026: Best Method of Tranexamic Acid Administration in Extracapsular Hip Fractures .
What is the Best Method of Tranexamic Acid Administration in Extracapsular Hip Fractures? A Meta-analysis of Randomized Controlled Trials
Fifteen randomized controlled trials including 1619 patients with extracapsular hip fractures were included comparing tranexamic acid (TXA) administration versus control. Pooled outcomes included thromboembolic events, hematoma formation, transfusion rates, intraoperative blood loss, hidden blood loss, total blood loss, and hemoglobin drop. Overall, TXA significantly reduced transfusion rates, intraoperative blood loss, hidden blood loss, total blood loss, and hemoglobin drop without increasing thromboembolic or hematoma risks. These findings suggest that TXA, particularly when administered pre-operatively and as a 10 mg/kg bolus dose, may be an effective strategy to reduce perioperative blood loss in extracapsular hip fractures.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
